Introduction
Disorders of neural function often involve abnormal electrical and neurochemical signalling in the central nervous system. To improve quality of life, patients undergo a variety of neuromodulation therapies. Deep brain stimulation is a commonly applied electrical technique with proven beneficial effects, despite some lack of understanding of its molecular mechanism of action (Kringelbach et al., 2007; Leeman and Cole, 2008; Olanow et al., 2004; Singh et al., 2007) . Localized drug delivery can also be used, by means of fluidic systems (Rossi et al., 2013; Whitesides, 2006) . However, these are often encumbered by accessory equipment (i.e., tubes, pumps, valves) and have difficulty in determining precise dosage.
Organic electronic electrophoretic transport devices -so called, iontronics -represent a new class of technologies that can provide spatiotemporal resolution and biochemical specificity.
Based on polyelectrolytes and π-conjugated semiconducting polymers, iontronics exhibit a unique combination of ionic and electronic properties, enabling transduction between electronic impulses and biochemical signals (Larsson et al., 2013) . This was first demonstrated in the organic electronic ion pump (OEIP), an electrophoretic delivery system which transports ions independently of liquid flow (Isaksson et al., 2007) . The technology is based on thin films of the electrically conducting polymer poly(3,4-ethylenedioxythiophene) (PEDOT) doped with the polyelectrolyte poly(styrenesulfonate) (PSS) (Heywang and Jonas, 1992) to provide enhanced electronic conductivity as well as cation-selective ionic conductivity. An OEIP consists of two PEDOT:PSS electrode strips on a plastic substrate, each passing through an electrolyte-filled reservoir (Fig. S1a) . One end of each strip is connected to a power supply, while immersion of the other ends in the target system forms a salt-bridge. When voltage is applied, positively charged substances in the source (anodic) reservoir are electrophoretically "pumped" into the target solution, without liquid flow. Simultaneously, cations are transported into the cathodic electrode/reservoir system, completing the electrochemical circuit. The precise electrochemistry of PEDOT:PSS enables delivery of one positively charged molecule for each electron involved in PEDOT:PSS redox, leading to extremely high dosage precision (Isaksson et al., 2007; Simon et al., 2009) .
A neuron can be considered a chemical-to-electrical-to-chemical signal transduction unit ( Fig.   1 ) able to convey information over long distances. Neurotransmitter binding incrementally depolarizes the cell membrane, generating an action potential of ionic currents at the axon hillock when threshold depolarization is reached. The action potential propagates along the cell membrane, leading to release of neurotransmitters at the axon terminal. Diffusion across the synaptic cleft enables neurotransmitter binding to receptors on the postsynaptic neuron. In this study, we developed an autoregulated electrochemical system, the organic electronic biomimetic neuron (OEBN), mimicking these fundamental aspects of neural function.
Chemical-to-electrical signal transduction is achieved by selective amperometric biosensors, which in turn regulate electrical-to-chemical delivery of neurotransmitters. This is the first demonstration of a regulated biosensor-OEIP system with the ability to precisely modulate delivery of neurotransmitters based on sensing of endogenous biochemical signals, thus mimicking neural function. The unique electronic communication interface allows the sensing component to be located at an arbitrary distance from the point of delivery, thereby expanding future applications to a variety of medical areas. 
2.
Materials and methods
Manufacturing and operation of OEIP
OEIP devices (Fig. S1 ) were manufactured by screen-printing PEDOT:PSS (Clevios SV3, H.C.
Starck) onto poly-ethylene terephthalate sheets pre-coated with PEDOT:PSS (Orgacon EL-350, Agfa-Gaevert). Double-electrode strips were prepared, and mounted in two-lumen polypropylene tubes, serving as anodic and cathodic chambers. The length of the delivery tip in final devices was ~7 mm. Upon electronic addressing of PEDOT:PSS, the anode is oxidized (1), and positively charged species (M + ) are liberated into the anode-side electrolyte. The cathode is reduced (2) and any cationic species (X + ) compensate the PSS -in the target system.
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The electrochemical potential established between the electrodes electrophoretically "pumps" the liberated M + into the target system, and X + is transported in toward the cathode. Devices were operated as described in Supplementary Materials and Methods.
Real--time pH recording
An OEIP filled with 100 mM HCl(aq) was immersed into a dish containing 100 mM NaCl(aq) and universal pH indicator (Fluka 36828) mounted on the stage of a stereo-microscope (Nikon SMZ1500). Color change at the submerged delivery tip was recorded by time-lapse video. pH was approximated by comparing the blue channel intensity of the video over time with the calibration colors of the indicator (Isaksson et al., 2008) .
Chemical sensing by amperometric biosensors
Commercial amperometric enzymatic biosensors utilize enzymatic reactions that oxidize or reduce the chemical component to be detected. This generates electrons available for electrical recording. The highly selective Glu sensor (7001, Pinnacle Technology) yields exactly two electrons for each Glu (3,4), and provides a sensor current directly proportional to [Glu] .
The ACh sensor (Sarissaprobe ACh, Sarissa Biomedical) yield four electrons from each ACh (5-7), and determines changes in [ACh] in environments lacking choline or with static [choline] .
The Glu sensor was operated at 600 mV versus the built-in Ag/AgCl wire reference, and the ACh sensor at 500 mV versus an external Ag/AgCl reference electrode (Bioanalytical Systems).
Voltage was applied and current recorded using a Keithley 2602 SourceMeter and custom LabVIEW software.
Cell cultivation and intracellular Ca 2+ recordings
Human neuroblastoma SH-SY5Y cells (ATCC no. CRL-2266) were handled according to supplier's instruction, and ratiometric Ca 2+ imaging was performed as previously described ) and detailed in the Supplementary Materials and Methods.
Results

Amperometric biosensors to determine activation thresholds
Neurons sense small concentration changes in the neurochemical environment and if threshold concentrations are reached, initiate action potentials. To mimic such sensing, real-time monitoring of [Glu] or [ACh] was demonstrated using commercially available, highly selective enzyme-based amperometric biosensors. To ascertain their ability to operate in complex cell medium, a Glu biosensor was first mounted in a dish containing Glu-free cell medium and the baseline sensor current was allowed to stabilize.
[Glu] was then increased stepwise from 5-80
µM, matching the concentration range reported for the synaptic cleft (2 µM-1 mM), brain extracellular fluid, and blood plasma (Meldrum, 2000) . With each increase, the biosensor current rose sharply within the first few seconds, before equilibrating at a level corresponding to the concentration step ( 
Threshold--induced activation of chemical delivery
Having established detection and translation of chemical signals into electrical currents, we coupled the biosensor to the OEIP to achieve a system for auto-regulated chemical delivery.
Electronically controlled transport and delivery through the tip of the OEIP is accomplished without any liquid flow, thereby mimicking the neuron's diffusive release of neurotransmitters.
To visualize this local release, we loaded an OEIP with 100 mM HCl(aq) and recorded the spatially resolved delivery of H + (Isaksson et al., 2008) in a dish containing universal pH indicator in 10 ml 100 µM NaCl(aq) (Fig. 3a) . A Glu biosensor, submerged in a separate sensing dish containing 10 ml PBS, was connected to the OEIP via control hardware and software.
[Glu] was increased stepwise in the sensing dish and the biosensor current was recorded (Fig. 3b) . Increasing [Glu] to 10 µM gave a sensor current of 6.3 nA, and further increase to 20 µM gave 9.2 nA. Both current levels were well below the arbitrarily defined The current recorded from the biosensor was used as input signal to the OEIP control software.
While the sensor current remained below threshold, the OEIP remained OFF and pH in the target dish stayed constant at pH 8 (Fig. 3c) . Exceeding the threshold (80 µM Glu at 860 s) turned the OEIP current ON, initiating H + delivery. This is observed as an immediate decrease of the pH in the target dish. The pH continued to decrease from 8 to < 3 during OEIP activation at 2.5 µA delivery current, which remained constant except for a momentary OFF switch due to agitation of the solution at the biosensor. Diluting Glu, resulting in a sensor current below 
Mimicking neurons in vitro: distant delivery and cell activation
In our development towards an auto-regulated neuromodulatory system, we next delivered the excitatory neurotransmitter ACh, a small positively charged molecule with high transport efficiency in the OEIP . As readout, adherent SH-SY5Y cells expressing ACh-receptors (AChRs) were used, since their binding of ACh can be detected by real-time Ca 2+ imaging. An OEIP filled with ACh was mounted with its delivery tip adjacent to cells loaded with the Ca 2+ dye Fura-2 AM (Fig. 3d) . The OEIP was connected through the control hard/software to an ACh biosensor in a separate dish. The software was programmed to initiate ACh delivery to the cells when the biosensor detected [ACh] ≥ 80 µM. After calibrating the ACh biosensor and allowing the current to stabilize, the baseline current was recorded in parallel with the basal intracellular Ca 2+ fluorescence (Fig. 3e ). An increase of [ACh] to 20 µM was insufficient to trigger OEIP delivery since it was below the arbitrarily set threshold.
Accordingly, no Ca 2+ response was observed. When increasing [ACh] to 80 µM, the preprogrammed threshold was exceeded. Approximately 500 s later, an increase in intracellular [Ca 2+ ] was observed as a shift in the fluorescence ratio. This experiment demonstrated how ACh fluxes at one site can be converted into ACh fluxes at a remote point.
Mimicking neurons in vitro: local sensing and cell activation
To demonstrate a more unified design of the auto-regulated system, the biosensor and OEIP were positioned in the same dish, adjacent to each other (Fig. 3f) . To demonstrate sensing and recording in close proximity within the same dish, Glu was used as biosensor input since SH-SY5Y cells are unresponsive due to incomplete expression of Glu receptors ( Fig. S3 and (Kulikov et al., 2007) Based on modelling of ACh delivery (Fig. S4) , this approx. 500 s delay seen in Fig. 3e (Kergoat et al., 2012 ). An increasing availability of miniaturized, selective and sensitive electrochemical biosensors for numerous chemical compounds (Marinesco and Dale, 2013; Turner, 2013) further expands future medical applications.
Discussion
The chemical delivery component, based on organic polyelectrolytes and π-conjugated conducting polymers, exhibits advantages such as flexibility, rheological compatibility with tissue, and ease of fabrication (Martin et al., 2010) . The electrochemical nature of delivery enables fine-tuned temporal control by prompt ON/OFF switching -a unique feature amongst delivery devices. The repertoire of deliverable substances, currently including mono-and divalent cations (Isaksson et al., 2007) , negatively charged species (Tybrandt et al., 2010) , aspartate, Glu, GABA and ACh , is likely to expand as material properties are being further developed.
Although current limitations, such as response time and size, prohibit true synaptic integration in its current format, OEBN technology can be envisaged in future therapeutic applications. 
Conclusions
We presented a biomimetic device able to reproduce the chemical-to-electrical-to-chemical signal transduction function of neurons. The organic electronic biomimetic neuron enabled neurotransmitter-regulated signaling over short and long distances, and effectively translated the sensing of one neurotransmitter into the release of another. This versatility offers a novel means for auto-regulated neuromodulation based on endogenous substances, enabling malfunctioning neuronal signalling pathways to be restored or augmented by the same chemical queues as present in the healthy state.
